Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C

Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women

Nasta P.
Maida I.
Cattelan A. M.
Pontali E.
Angeli E.
Giralda M.
Verucchi G.
Caputo A.
Iannacone C.
Puoti M.
Carosi G.

January 2015

Background: This was a post-hoc analysis of the Optimized Pegylated interferons Efficacy and anti-Re...

Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil

Calvet, Guilherme Amaral
Velasque, Luciane de Souza
Luz, Paula Mendes
Cardoso, Sandra Wagner
Pedrosa, Monica Derrico
Moreira, Ronaldo Ismério
Andrade, Angela Cristina Vasconcelos de
Cytryn, Andrea
Pires, Elaine
Santos, Valdiléa Gonçalves Veloso dos
Grinsztejn, Beatriz Gilda Jegerhorn
Friedman, Ruth Khalili

January 2014

Objective: To compare the effectiveness of first-line combination antiretroviral therapy (cART) betw...

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients

Frei, Pascal
Leucht, Anna-Kathrin
Held, Ulrike
Kofmehl, Reto
Manser, Christine N
Schmitt, Johannes
Mertens, Joachim
Rau, Monika
Baur, Katharina
Gerlach, Tilman Joern
Negro, Francesco
Heim, Markus
Moradpour, Darius
Cerny, Andreas
Dufour, Jean-François Jacques
Müllhaupt, Beat
Geier, Andreas

January 2014

Age is frequently discussed as negative host factor to achieve a sustained virological response (SVR...

Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C

Gitto S
Karampatou A
Andreone P
VILLA, Erica

January 2012

Letter commenting the fact that menopause and not age is a key factor for resistance to IF

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C

Villa E
Karampatou A
Cammà C
Di Leo A
Luongo M
Ferrari A
Petta S
Losi L
Taliani G
Trande P
Lei B
Graziosi A
Bernabucci V
Critelli R
Pazienza P
Rendina M
Antonelli A
Francavilla A.

January 2011

BACKGROUND & AIMS:Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and meno...

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

Villa E
Karampatou A
Cammà C
Di Leo A
Luongo M
Ferrari A
Petta S
Losi L
Taliani G
Trande P
Lei B
Graziosi A
Bernabucci V
Critelli R
Pazienza P
Rendina M
Antonelli A
Francavilla A.

January 2011

BACKGROUND AND AIMS: Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and ...

Impact of menopause on the clinical management of chronic hepatitis c in women

Villa E.
Bernabucci V.

January 2010

The liver, although not a classical target for estrogens, is sensitive to their effects, particularl...

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.

Villa E
Cammà C
Di Leo A
Karampatou A
Enea M
Gitto S
Bernabucci V
Losi L
De Maria N
Lei B
Ferrari A
Vukotic R
Vignoli P
Rendina M
Francavilla A

January 2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been...

Peginterferon-A_2B plus ribavirin is more effective than peginterferon-A_2A plus ribavirin in menopausal women with chronic hepatitis C

Villa, E
Di Leo, A
Karampatou, A
Gitto, S
Bernabucci, V
Losi, L
De Maria, N
Lei, B
Ferrari, A
Vukotic, R
Vignoli, P
Rendina, M
Francavilla, A.
CAMMA', Calogero
ENEA, Marco

January 2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been...

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C

VILLA, Erica
BERNABUCCI, Veronica
VUKOTIC, Ranka
Cammà C
Di Leo A
Karampatou A
Enea M
Gitto S
Losi L
De Maria N
Lei B
Ferrari A
Vignoli P
Rendina M
Francavilla A.

January 2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been...

The role played by gender in viral hepatitis

BERNABUCCI, Veronica
VILLA, Erica

January 2014

Although not a classical target for estrogens, the liver is a target for their action and is sensiti...

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients.

Frei, P.
Leucht, A.K.
Held, U.
Kofmehl, R.
Manser, C.N.
Schmitt, J.
Mertens, J.
Rau, M.
Baur, K.
Gerlach, T.
Negro, F.
Heim, M.
Moradpour, D.
Cerny, A.
Dufour, J.F.
Müllhaupt, B.
Geier, A.

January 2014

BACKGROUND & AIMS: Age is frequently discussed as negative host factor to achieve a sustained vi...

Age above 60 years is not a negative predictive factor for combined antiviral therapy with pegylated interferon alpha and ribavirin in hepatitis C patients

Frei, P.
Leucht, A.K.
Held, U.
Kofmehl, R.
Schmitt, J.
Rau, M.
Gerlach, T.
Negro, F.
Heim, M.H.
Moradpour, D.
Cerny, A.
Dufour, J.F.
Mullhaupt, B.
Geier, A.

January 2011

Background: Age is frequently discussed as negative host factor to achieve a sustained virological r...

Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) Infection

Nora H. Ahmed
Taghrid B. El-Abaseri
Hesham F. El-Sayed
Taher I. El-Serafi

January 2015

Chronic hepatitis C (CHC) course revealed differences between men and women. Male gender and postmen...

Can gender predict virological response to standard antiviral therapy for chronic hepatitis C? A retrospective study

Belci, Paola
Collo, Alessandro
Martorana, Maria
Evangelista, Andrea
Giunti, Sara
Gambino, Roberto
Cassader, Maurizio
Bo, Simona
Durazzo, Marilena

May 2016

Aim: The liver is a sexually dimorphic organ presenting gender differences in its metabolism, functi...

Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women

Nasta P.
Maida I.
Cattelan A. M.
Pontali E.
Angeli E.
Giralda M.
Verucchi G.
Caputo A.
Iannacone C.
Puoti M.
Carosi G.

January 2015

Background: This was a post-hoc analysis of the Optimized Pegylated interferons Efficacy and anti-Re...

Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil

Calvet, Guilherme Amaral
Velasque, Luciane de Souza
Luz, Paula Mendes
Cardoso, Sandra Wagner
Pedrosa, Monica Derrico
Moreira, Ronaldo Ismério
Andrade, Angela Cristina Vasconcelos de
Cytryn, Andrea
Pires, Elaine
Santos, Valdiléa Gonçalves Veloso dos
Grinsztejn, Beatriz Gilda Jegerhorn
Friedman, Ruth Khalili

January 2014

Objective: To compare the effectiveness of first-line combination antiretroviral therapy (cART) betw...

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients

Frei, Pascal
Leucht, Anna-Kathrin
Held, Ulrike
Kofmehl, Reto
Manser, Christine N
Schmitt, Johannes
Mertens, Joachim
Rau, Monika
Baur, Katharina
Gerlach, Tilman Joern
Negro, Francesco
Heim, Markus
Moradpour, Darius
Cerny, Andreas
Dufour, Jean-François Jacques
Müllhaupt, Beat
Geier, Andreas

January 2014

Age is frequently discussed as negative host factor to achieve a sustained virological response (SVR...

Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C

Gitto S
Karampatou A
Andreone P
VILLA, Erica

January 2012

Letter commenting the fact that menopause and not age is a key factor for resistance to IF

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C

Villa E
Karampatou A
Cammà C
Di Leo A
Luongo M
Ferrari A
Petta S
Losi L
Taliani G
Trande P
Lei B
Graziosi A
Bernabucci V
Critelli R
Pazienza P
Rendina M
Antonelli A
Francavilla A.

January 2011

BACKGROUND & AIMS:Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and meno...

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

Villa E
Karampatou A
Cammà C
Di Leo A
Luongo M
Ferrari A
Petta S
Losi L
Taliani G
Trande P
Lei B
Graziosi A
Bernabucci V
Critelli R
Pazienza P
Rendina M
Antonelli A
Francavilla A.

January 2011

BACKGROUND AND AIMS: Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and ...

Impact of menopause on the clinical management of chronic hepatitis c in women

Villa E.
Bernabucci V.

January 2010

The liver, although not a classical target for estrogens, is sensitive to their effects, particularl...

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.

Villa E
Cammà C
Di Leo A
Karampatou A
Enea M
Gitto S
Bernabucci V
Losi L
De Maria N
Lei B
Ferrari A
Vukotic R
Vignoli P
Rendina M
Francavilla A

January 2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been...

Peginterferon-A_2B plus ribavirin is more effective than peginterferon-A_2A plus ribavirin in menopausal women with chronic hepatitis C

Villa, E
Di Leo, A
Karampatou, A
Gitto, S
Bernabucci, V
Losi, L
De Maria, N
Lei, B
Ferrari, A
Vukotic, R
Vignoli, P
Rendina, M
Francavilla, A.
CAMMA', Calogero
ENEA, Marco

January 2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been...

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C

VILLA, Erica
BERNABUCCI, Veronica
VUKOTIC, Ranka
Cammà C
Di Leo A
Karampatou A
Enea M
Gitto S
Losi L
De Maria N
Lei B
Ferrari A
Vignoli P
Rendina M
Francavilla A.

January 2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been...

The role played by gender in viral hepatitis

BERNABUCCI, Veronica
VILLA, Erica

January 2014

Although not a classical target for estrogens, the liver is a target for their action and is sensiti...

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients.

Frei, P.
Leucht, A.K.
Held, U.
Kofmehl, R.
Manser, C.N.
Schmitt, J.
Mertens, J.
Rau, M.
Baur, K.
Gerlach, T.
Negro, F.
Heim, M.
Moradpour, D.
Cerny, A.
Dufour, J.F.
Müllhaupt, B.
Geier, A.

January 2014

BACKGROUND & AIMS: Age is frequently discussed as negative host factor to achieve a sustained vi...

Age above 60 years is not a negative predictive factor for combined antiviral therapy with pegylated interferon alpha and ribavirin in hepatitis C patients

Frei, P.
Leucht, A.K.
Held, U.
Kofmehl, R.
Schmitt, J.
Rau, M.
Gerlach, T.
Negro, F.
Heim, M.H.
Moradpour, D.
Cerny, A.
Dufour, J.F.
Mullhaupt, B.
Geier, A.

January 2011

Background: Age is frequently discussed as negative host factor to achieve a sustained virological r...

Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) Infection

Nora H. Ahmed
Taghrid B. El-Abaseri
Hesham F. El-Sayed
Taher I. El-Serafi

January 2015

Chronic hepatitis C (CHC) course revealed differences between men and women. Male gender and postmen...

Can gender predict virological response to standard antiviral therapy for chronic hepatitis C? A retrospective study

Belci, Paola
Collo, Alessandro
Martorana, Maria
Evangelista, Andrea
Giunti, Sara
Gambino, Roberto
Cassader, Maurizio
Bo, Simona
Durazzo, Marilena

May 2016

Aim: The liver is a sexually dimorphic organ presenting gender differences in its metabolism, functi...

Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women

Nasta P.
Maida I.
Cattelan A. M.
Pontali E.
Angeli E.
Giralda M.
Verucchi G.
Caputo A.
Iannacone C.
Puoti M.
Carosi G.

January 2015

Background: This was a post-hoc analysis of the Optimized Pegylated interferons Efficacy and anti-Re...

Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil

Calvet, Guilherme Amaral
Velasque, Luciane de Souza
Luz, Paula Mendes
Cardoso, Sandra Wagner
Pedrosa, Monica Derrico
Moreira, Ronaldo Ismério
Andrade, Angela Cristina Vasconcelos de
Cytryn, Andrea
Pires, Elaine
Santos, Valdiléa Gonçalves Veloso dos
Grinsztejn, Beatriz Gilda Jegerhorn
Friedman, Ruth Khalili

January 2014

Objective: To compare the effectiveness of first-line combination antiretroviral therapy (cART) betw...

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients

Frei, Pascal
Leucht, Anna-Kathrin
Held, Ulrike
Kofmehl, Reto
Manser, Christine N
Schmitt, Johannes
Mertens, Joachim
Rau, Monika
Baur, Katharina
Gerlach, Tilman Joern
Negro, Francesco
Heim, Markus
Moradpour, Darius
Cerny, Andreas
Dufour, Jean-François Jacques
Müllhaupt, Beat
Geier, Andreas

January 2014

Age is frequently discussed as negative host factor to achieve a sustained virological response (SVR...

Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C

Abstract

Extracted data

Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C

Abstract

Extracted data

Related items

Related items